Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-26 @ 1:42 AM
NCT ID: NCT00244933
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00244933
Study Brief: Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Gemcitabine & Genistein Gemcitabine, genistein (Novasoy), Tumor biopsy Gemcitabine IV-1000mg/m2: Days 1 \& 8 every 21 days: Novasoy Orally-100 mg 2 times/day for 7 days; 2 times/day on Days 1-21 every 21 days. None None 5 19 2 19 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Platelets SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Dyspnea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
White blood cells (WBC) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Hemoglobin (Hgb) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Absolute neutrophil count (ANC) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Elevated Aspartate Aminotransferase (AST) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Elevated Alanine Aminotransferase (ALT) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Pain SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hemoglobin (Hgb) SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Platelets SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Elevated Alkaline Phosphate SYSTEMATIC_ASSESSMENT Investigations CTCAE (3.0) View
Pain SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Hot flashes SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (3.0) View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View